… Drug treatment is justified in older patients with isolated systolic hypertension whose
systolic blood pressure is 160 mm Hg or higher. Absolute benefit is larger in men, in …

… We conclude that thalidomide added to MP improves OS and PFS in previously untreated
elderly patients with multiple myeloma, extending the median survival time by on average 20%…

8130 Background: Randomized clinical trials including previously untreated patients were
initiated in Italy, France (2), Netherlands/Belgium, and Nordic countries in 2000-2002 and in …

… The World Health Organization defines elderly persons as those aged ≥65 years; however,
… in the risk of infection in older patients.141 In this study, azathioprine appeared to be better …

… We conducted a network meta-analysis using fixed and random … study was to conduct a
network meta-analysis to compare relative treatment effects of therapies for previously untreated …

… In conclusion, particular attention should be given to hypertensive elderly patients who
constitute a large, growing and vulnerable population. Treating hypertension in very old …

… in older patients with CD33 positive AML cells, based on improvement in Median OS from
3.6 in the control best supportive care arm (n = 119) to 4.9 months in the GO arm (n = 118), HR …

… In conclusion, this is the first-meta-analysis to specifically assess the role of MTAs in the
treatment of elderly patients with mCRC. Our study confirms that the addition of MTAs to the …

… Immune checkpoint inhibitor (ICI) therapy has improved patient survival in advanced … ICIs
in elderly patients is still elusive. This study assessed the efficacy of ICIs in elderly patients with …

… survival endpoints in previously untreated MM patients ineligible for ASCT. In this analysis,
Rd … However, the OS benefit in the VMP group did not apply to elderly patients (≥75 years).[…